The short version of plasma peptide fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-01-31 and is reviewed periodically as new material appears.
Published work on GHK-Cu concentrates largely on cell culture systems rather than whole organisms. Frequently used endpoints include collagen synthesis, expression of matrix metalloproteinases, and migration of fibroblasts. Some reports describe antioxidant behavior, while others stress delivery of copper into cells. These mechanisms are proposed rather than demonstrated, and the relative weight of each pathway is unclear. Human trials are few and generally small, so laboratory findings should not be read as confirmed clinical results.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide backbone consists of glycine, histidine, and lysine joined in that order. Copper is held through the imidazole nitrogen of histidine and the alpha-amino group at the N-terminus, which together produce a square-planar arrangement around the metal center. The solid appears blue to violet, a color that originates from d-d electronic transitions within the copper coordination sphere. The complex is indexed under CAS number 89030-95-5.
Identity and purity are established with a combination of chromatographic and spectroscopic techniques. Reversed-phase high-performance liquid chromatography separates the intact complex from peptide fragments and free copper, and the elution profile yields a purity estimate. Mass spectrometry gives the mass of the intact species and exposes degradation products. Ultraviolet-visible spectroscopy displays a broad absorption band in the visible region that is characteristic of the copper center. Nuclear magnetic resonance is less informative here, because the paramagnetic metal broadens signals and complicates spectral interpretation.
Copper content is measured separately, since a peptide assay alone does not report the metal-to-peptide ratio. Elemental techniques such as inductively coupled plasma optical emission spectroscopy quantify copper after acid digestion of the sample. The result is compared with the theoretical value for a one-to-one complex, and a shortfall indicates free peptide or partial dissociation. Suppliers differ in how they state purity, as some quote peptide content and others quote the whole complex. A defined stoichiometry therefore requires both a peptide assay and a copper assay.
Solid GHK-Cu is usually supplied as a lyophilized powder and is kept cold and dry. Moisture, light, and repeated temperature cycling shorten its useful life in the laboratory. In aqueous solution the complex undergoes slow hydrolysis of the peptide backbone and gradual loss of coordinated copper. Buffers containing strong chelators, such as EDTA, compete for the metal and strip it from the peptide. Working solutions are therefore prepared shortly before use, and leftover liquid is not returned to the stock container.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Copper(II) peptide complex | Peptide chain coordinated to a single metal ion |
| CAS number | 89030-95-5 | Indexed for the peptide-copper complex |
| Molecular formula | C14H22CuN6O4 | Approximate formula for a one-to-one complex |
| Appearance | Blue to violet solid | Color from copper d-d transitions |
| Solubility class | Freely soluble in water | Also dispersible in some polar solvents |
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and copper(II). The peptide sequence consists of glycine, histidine, and lysine, and its imidazole and amino groups provide binding sites for the metal ion. In the complex, copper is held through nitrogen donors from the histidine side chain, the N-terminal amine, and deprotonated amide nitrogens. The resulting compound is intensely blue and water-soluble. It occurs naturally in human plasma, saliva, and urine at low concentrations.
The peptide was first isolated from human albumin in 1973 by Loren Pickart, who later described its copper-binding behavior. Early work linked the complex to wound healing and tissue remodeling. Plasma levels of GHK decline with age, a pattern that stimulated interest in topical and supplemental applications. Researchers have reported that the tripeptide influences collagen synthesis, antioxidant defense, and inflammatory signaling in cell and animal models. Human clinical evidence remains limited and often relies on small studies.
Routine handling calls for minimizing freeze-thaw cycles and preparing solutions shortly before use. Glass or inert plastic containers reduce adsorption and metal leaching. Working stocks are often kept at 2–8 °C for short periods, while long-term reference material stays at −20 °C or below. Light protection is prudent because prolonged exposure may accelerate oxidation of the peptide. Documentation of lot number, concentration, and preparation date supports reproducibility in laboratory work.
Analytical verification typically combines reversed-phase high-performance liquid chromatography with ultraviolet-visible detection. The copper complex absorbs visible light near 600–630 nm, giving a characteristic blue signal. Mass spectrometry confirms molecular mass and can detect free peptide or mismatched copper stoichiometry. Copper content is often measured independently by inductively coupled plasma mass spectrometry or atomic absorption spectroscopy. Purity, counterion identity, and residual solvents are additional quality-control parameters that methods may address.
Solid GHK-Cu is generally stored as a dry powder under frozen conditions to limit degradation. The peptide bond can hydrolyze, and the copper center can be displaced by strong chelators such as EDTA. Aqueous solutions are less stable than the solid and may lose color or form precipitates over time. Temperature, pH, and oxygen exposure are the main variables that affect shelf life. Neutral to slightly acidic conditions tend to preserve the complex better than strongly alkaline media.
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, a short sequence of three amino acids. The peptide was first isolated from human plasma in 1973 during research on factors that influence tissue repair in liver. Its ability to bind copper ions became a central point of interest because the metal changes the peptide's chemistry and its behaviour in laboratory systems. Today the compound appears in cosmetic formulations, cell-culture studies, and biochemistry literature under several names.
The peptide sequence places a histidine in the middle, and this residue dominates metal binding. Copper(II) coordinates through the imidazole nitrogen of histidine and the terminal amino group, forming a stable chelate ring system. Loss of the copper ion leaves the free tripeptide, which has different solubility and reactivity. This structural detail matters because assays that measure only the peptide backbone can miss whether copper is still bound to it.
Several names circulate for the same material, which complicates literature searches. Cosmetic ingredient lists often use copper tripeptide-1, while older biochemistry papers use glycyl-L-histidyl-lysine or its abbreviation GHK. The copper complex is sometimes written as GHK-Cu(II) to make the oxidation state explicit. Terminology is not fully standardized, so matching a compound across sources requires attention to the exact sequence, the counterion, and the stated copper content. Reviews that compare studies must account for these naming differences before drawing conclusions.
== Early life == He was born in the Potsdamer Stadtschloss when his grandfather was still the Crown Prince of Prussia. He spent his youth with his siblings at the New Palace, also in Potsdam, and his school days with his brothers at the Prinzenhaus in Plön in his mother's ancestral Schleswig-Holstein. Later, he studied at the universities of Bonn, Berlin and Strasbourg. He received his doctorate in political science in 1907.
EC 2.1 includes enzymes that transfer single-carbon groups. This category consists of transfers of methyl, hydroxymethyl, formyl, carboxy, carbamoyl, and amido groups. Carbamoyltransferases, as an example, transfer a carbamoyl group from one molecule to another. Carbamoyl groups follow the formula NH2CO. In ATCase such a transfer is written as carbamoyl phosphate + L-aspartate
=== Reservoir === Unlike the single-layer and multi-layer drug-in-adhesive systems, the reservoir transdermal system has a separate drug layer. The drug layer is a liquid compartment containing a drug solution or suspension separated by the adhesive layer. The drug reservoir is totally encapsulated in a shallow compartment molded from a drug-impermeable metallic plastic laminate, with a rate-controlling membrane made of a polymer like vinyl acetate on one surface. This patch is also backed by the backing layer. In this type of system the rate of release is zero order. Reservoir patches should not be cut (with the exception of hyoscine hyrdobromide 1.5mg patch according to the British National Formulary for Children).
=== Vacuum system === The specimen should be in a high-vacuum environment for optimal milling results. The vacuum makes sure that there are few air particles that could interfere with the ion beam. This way, all the energy in the energy beam can be transferred to the surface with much less energy loss.
Sources: en.wikipedia.org
In South India, across the first millennium CE, the Middle kingdoms transmitted Dravidian language scripts and cultural traditions to Southeast Asia. Well before the millennium's end, Judaism, Christianity, Islam, and Zoroastrianism had become established on India's southern and western coasts. Early in the 2nd millennium, Muslim armies from Central Asia intermittently overran India's northern plains, eventually establishing the Delhi Sultanate and drawing India into the cosmopolitan networks of medieval Islam. The Vijayanagara Empire established a powerful military-fiscal state that fostered a flourishing, distinctively South Indian Hindu culture. During this era, Sikhism emerged in the Punjab, promoting an egalitarian devotion that transcended traditional Hindu and Muslim boundaries. The Mughal Empire ushered in two centuries of economic expansion and relative peace, leaving a lasting legacy of administrative centralisation and cultural synthesis. The expanding rule of the British East India Company consolidated territorial control over the subcontinent while transforming India into a colonial economy. Crown rule, or the British Raj, began in 1858. Although equality before the law promised to Indians was slow to materialise, both British India and, to a lesser extent, the princely states saw technological changes as modern education and more organised public life took root. A nationalist movement emerged in India, the first in the non-European British Empire. Noted for nonviolent resistance after 1920, it was a major factor in ending British rule.
==== Biotextile scaffolds for tissue regeneration ==== The development of a collagen biotextile scaffold for aiding in the healing process of large deep burn wounds has been achieved by researchers at UC Davis. This scaffold, utilizing a specially engineered biomaterial, has demonstrated efficacy in promoting the formation of new blood vessels and reducing complications associated with severe burns. The study highlights the scaffold's ability to accelerate wound healing in mouse models and mitigate burn-related complications such as fluid loss and infection. Through testing different scaffold types, the research team observed that the combined treatment loaded with endothelial cells exhibited the highest wound healing rate.
The first arc of the series, Trails in the Sky, consists of three games. They are set within the Liberl Kingdom and primarily follow Estelle Bright and her adopted brother Joshua, members of the Bracer's Guild, a civilian peacekeeping and monster-hunting organization. The first game, Trails in the Sky, was released in Japan in 2004 for Windows and for the PlayStation Portable (PSP) in 2006. The second game, Trails in the Sky SC, continues the plot of the first and was released in Japan for Windows in 2006 and the PSP the following year. The third game, Trails in the Sky the 3rd, follows Septian Church agent Kevin Graham, who is sent to an otherworldly dimension known as Phantasma alongside many characters from the previous two games. Sky the 3rd also features vignettes exploring character backstories as well as foreshadowing plot elements explored in later arcs. It was released in Japan in 2007 for Windows and the PSP in 2008. A 3D remake of the first game, Trails in the Sky 1st Chapter, released worldwide for Nintendo Switch, Nintendo Switch 2, PlayStation 5, and Windows in 2025. A remake of the sequel, Trails in the Sky 2nd Chapter, has been released for the same platforms in 2026. In 2010, Xseed Games acquired the rights to localize and publish the trilogy in English.
Sources: en.wikipedia.org
== Human genes == 45S: RNR1, RNR2, RNR3, RNR4, RNR5; (unclustered) RNA18SN1, RNA18SN2, RNA18SN3, RNA18SN4, RNA18SN5, RNA28SN1, RNA28SN2, RNA28SN3, RNA28SN4, RNA28SN5, RNA45SN1, RNA45SN2, RNA45SN3, RNA45SN4, RNA45SN5, RNA5-8SN1, RNA5-8SN2, RNA5-8SN3, RNA5-8SN4, RNA5-8SN5 5S: RNA5S1, RNA5S2, RNA5S3, RNA5S4, RNA5S5, RNA5S6, RNA5S7, RNA5S8, RNA5S9, RNA5S10, RNA5S11, RNA5S12, RNA5S13, RNA5S14, RNA5S15, RNA5S16, RNA5S17 Mt: MT-RNR1, MT-TV (co-opted), MT-RNR2
== Application == GPC is often used to determine the relative molecular weight of polymer samples as well as the distribution of molecular weights. What GPC truly measures is the molecular volume and shape function as defined by the intrinsic viscosity. If comparable standards are used, this relative data can be used to determine molecular weights within ± 5% accuracy. Polystyrene standards with dispersities of less than 1.2 are typically used to calibrate the GPC. Unfortunately, polystyrene tends to be a very linear polymer and therefore as a standard it is only useful to compare it to other polymers that are known to be linear and of relatively the same size.
=== Sevilla === 777 Partners' first investment in soccer was to purchase a minority stake in Spanish La Liga club Sevilla FC in 2018. In 2020, it elevated its share to 7.5%. 777 does not legally own shares in Sevilla as its involvement is as the owner of a group called Sevillistas Unidos S.L.. The latter organization has denounced 777 for listing Sevilla as one of "Our Portfolio Brands" on its website. Sevilla had been identified by 777 Partners as an opportunity for investment due to their focus on buying and selling players under sporting director Monchi. Their investment had been greeted with suspicion due to the club's history of being owned by local dynasties. 777 Partners' investment around Sevilla was allegedly funded in part by a loan from Oleg Boyko, a Russian businessman sanctioned by several countries for reported connections to the Russian state. In 2024, Boyko allegedly demanded 777's shares in Sevilla as collateral for his loan.
== Genes == Fibrinogen is made and secreted into the blood primarily by liver hepatocyte cells. Endothelium cells are also reported to make small amounts of fibrinogen, but this fibrinogen has not been fully characterized; blood platelets and their precursors, bone marrow megakaryocytes, while once thought to make fibrinogen, are now known to take up and store but not make the glycoprotein. The final secreted, hepatocyte-derived glycoprotein is composed of two trimers, with each trimer composed of three different polypeptide chains, the fibrinogen alpha chain (also termed the Aα or α chain) encoded by the FGA gene, the fibrinogen beta chain (also termed the Bβ or β chain) encoded by the FGB gene, and the fibrinogen gamma chain (also termed the γ chain) encoded by the FGG gene. All three genes are located on the long or "q" arm of human chromosome 4 (at positions 4q31.3, 4q31.3, and 4q32.1, respectively).
Sources: en.wikipedia.org
It is the copper complex of the tripeptide glycyl-L-histidyl-lysine. The metal ion is held by the histidine imidazole group and the peptide N-terminus. Most research on it concerns skin and wound models.
The tripeptide was first isolated from human plasma and has also been reported in saliva and urine. Plasma levels appear to decline with age in some small studies. Those observations rest on limited sample sizes.
It is not authorized as a systemic medicine in most countries. Cosmetic preparations list it as an ingredient rather than an active pharmaceutical substance. Legal status therefore differs by jurisdiction.
Lyophilized material is normally held at about minus twenty degrees Celsius in a sealed, desiccated vial. Dissolved samples are less durable and are prepared fresh. Repeated freeze-thaw cycles are avoided.